AzTrials
AzTrials

Immediate ImplantNCT05878392

Immediate Implant With Different Filling Materials

A study testing bone filling materials in people with Immediate Implant, run by Mansoura University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

36 patients, were included in this study. They were chosen from the Outpatient Clinic in the Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Mansoura University for replacement of non-restorable maxillary anterior and premolar teeth (esthetic zone) by immediate implant. Read more about this study

Who is it for?
Ages 18 to 45 yearsHealthy volunteers can take part
Conditions the study is for
Immediate Implant
What is being tested?
bone filling materials
Could I receive a placebo?
No, everyone receives an active treatment
How many people
36 participants
Where
1 siteEgypt
Study dates
1 Jan 2022to 1 Jan 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Patient medically free from systemic diseases.
  • Age above 18 years.
  • A single maxillary anterior or premolar tooth that cannot be restored.
  • No acute infection is present.
  • Patients with sufficient quality and quantity of bone.
  • Free from history of bruxism.

Who cannot join

  • A medical condition that would prevent implant surgery.
  • Existence of non-treated generalized progressive periodontitis.
  • Patients who are smokers.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Heba Elsheikh

    Mansoura, Egypt, 002

Other trials in Egypt

About this study

Official title: Comparison Between Different Filling Materials in Immediate Implant

36 patients, were included in this study. They were chosen from the Outpatient Clinic in the Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Mansoura University for replacement of non-restorable maxillary anterior and premolar teeth (esthetic zone) by immediate implant.

Being tested
bone filling materials

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • bone filling materialsOther

    the buccal jumping gap was packed using PRF in group 1 the buccal jumping gap was packed using xenograft in group 2 the buccal jumping gap was packed using Alloplastic β-tricalcium phosphate in group 3

Study groups in NCT05878392
Study groupRoleWhat they receive
group 1Experimentalimmediate implant placement and the buccal jumping gap was packed using PRF
Receives: Other: bone filling materials
group 2Experimentalimmediate implant placement and the buccal jumping gap was packed using xenograft
Receives: Other: bone filling materials
group 3Experimentalimmediate implant placement and the buccal jumping gap was packed using alloplast
Receives: Other: bone filling materials

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. marginal bone loss

    Cone Beam CT (CBCT) was used measure marginal bone loss

    Measured: 1 year

Secondary outcomes (2)
  1. Implant Stability:

    Resonance frequency analysis (RFA) was used to measure implant stability with an Osstell Mentor device.

    Measured: 1 year

  2. Peri-implant Pocket depth

    A graduated probe was used to measure the distance between the base of the pocket and the gingival margin

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 May 2023
  2. Study start1 Jan 2022
  3. Primary completion1 Jun 2022
  4. Study completion1 Jan 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
36 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05878392
Sponsor's protocol ID
A0103023OS
Status last verified
May 2023
First submitted
9 May 2023
Last updated
26 May 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Elsheikh HA, Abdelsameaa SE, Elbahnasi AA, Abdel-Rahman FH. Comparison between platelet rich fibrin as space filling material versus xenograft and alloplastic bone grafting materials in immediate implant placement: a randomized clinical trial. BMC Oral Health. 2023 Dec 8;23(1):977. doi: 10.1186/s12903-023-03678-5.

    PubMed 38066454

Questions about this trial

What is this clinical trial studying?

A study testing bone filling materials in people with Immediate Implant, run by Mansoura University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

marginal bone loss (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05878392, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 May 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in